Fujian Wanchen Biotechnology Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 761.86 million compared to CNY 116.63 million a year ago. Revenue was CNY 761.86 million compared to CNY 116.63 million a year ago.

Net income was CNY 52.63 million compared to CNY 24.32 million a year ago. Basic earnings per share from continuing operations was CNY 0.3429 compared to CNY 0.1585 a year ago. Diluted earnings per share from continuing operations was CNY 0.3372 compared to CNY 0.1585 a year ago.